Search PubMedSearch

PubMed · 6274366

[Perspectives on immunologic damage].

Abstract

The most important steps followed by the science of Immunology since the end of last century to attain the knowledge on the subpopulations of T and B lymphocytes are summarized. General immunologists observed that the immune response could have adverse effects to the host. First, it was the observation of anaphylaxis and the reaction to tuberculin; next, the term hypersensitivity was coined and finally, four different mechanisms of the immunologic harm were characterized. Through the last years, a fifth hypersensitivity mechanism has been proposed where of the function of the cells having membrane receptors are damaged and against which, autoantibodies are formed. This autoimmune response may block or may stimulate the receptors. The author analyses the perspectives had by this mechanism of "cellular function altered by autoantibodies against membrane receptors". An important tissular damage does not exist like in the other hypersensitivity mechanisms, but there is rather a change in the biological activity of a tissue, due to the fact that several of its receptors become blocked or are stimulated.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

F García Tamayo. [Perspectives on immunologic damage].. https://pubmed.ncbi.nlm.nih.gov/6274366/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

B lymphocytes from patients with chronic lymphocytic leukemia contain signal transducer and activator of transcription (STAT) 1 and STAT3 constitutively phosphorylated on serine residues.

To explore the pathogenesis of chronic lymphocytic leukemia (CLL), we examined whether phosphorylation of one or more signal transducer and activator of transcription (STAT) factors was abnormal in cells from CLL patients. No constitutive tyrosine phosphorylation was detected on any STAT in CLL cells. To assess the phosphorylation of serine residues of STAT1 and STAT3 in CLL cells, we raised antibodies that specifically recognize the form of STAT1 phosphorylated on ser-727 and the form of STAT3 phosphorylated on ser-727. We found that in 100% of patients with CLL (n = 32), STAT1 and STAT3 were constitutively phosphorylated on serine. This was in contrast to normal peripheral blood B lymphocytes or CD5+) B cells isolated from tonsils, in which this phosphorylation was absent. Serine phosphorylation of STAT1 and STAT3 was seen occasionally in other leukemias, but it was a universal finding only in CLL. The serine phosphorylation of these STATs was a continuous process, as incubation of CLL cells with the kinase inhibitor H7 led to the dephosphorylation of these serine residues. The STAT serine kinase in CLL cells has not been identified, and appears to be neither mitogen-activated protein kinase nor pp70(s6k). In summary, the constitutive serine phosphorylation of STAT1 and STAT3 is present in all CLL samples tested to date, although the physiologic significance of this modification remains to be determined.

Antibody Formation

Immunotherapy with allergens.

Allergen immunotherapy has been shown to be efficacious in numerous studies for the clinical indications of allergic asthma and rhinitis, as well as hymenoptera venom hypersensitivity. How allergen immunotherapy improves clinical symptoms is still not entirely clear. Decreases in specific IgE follow a complex cascade of effects: a shifting of the cytokine milieu from T(H)2 to T(H)1 predominance, with resultant decrease in interleukin 4, decreased recruitment and activation of eosinophils, and decreased proliferation of mast cells. Allergen exposure has a lessened ability to stimulate an inflammatory cell response, with decreased target organ hyperreactivity. Since allergen immunotherapy is not without risk, the decision needs to be made whether injection therapy is safe and provides benefit not achievable by medical management. The continued clarification of optimal allergen concentrations through careful studies of standardized extracts will allow better control of adverse events by limiting unnecessarily potent mixtures.

Antibody Formation